SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021029
Filing Date
2018-08-09
Accepted
2018-08-09 16:02:41
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20180630.htm 10-Q 1789172
2 EX-31.1 cbay-ex311_7.htm EX-31.1 15438
3 EX-31.2 cbay-ex312_9.htm EX-31.2 15341
4 EX-32.1 cbay-ex321_8.htm EX-32.1 8012
  Complete submission text file 0001564590-18-021029.txt   7281900

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20180630.xml EX-101.INS 2025921
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20180630.xsd EX-101.SCH 37746
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20180630_cal.xml EX-101.CAL 42914
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20180630_def.xml EX-101.DEF 103808
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20180630_lab.xml EX-101.LAB 284173
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20180630_pre.xml EX-101.PRE 215445
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 181004953
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences